The Burden of Age-Related Macular Degeneration Jordana K. SchmierMechelle L. JonesMichael T. Halpern Leading Article 09 October 2012 Pages: 319 - 334
Economic and Developmental Considerations for Pharmacogenomic Technology John A. VernonScott J. JohnsonAntonio Trujillo Leading Article 09 October 2012 Pages: 335 - 343
Optimal Assignment of Treatments to Health States Using a Markov Decision Model Mohan V. BalaJosephine A. Mauskopf Leading Article 09 October 2012 Pages: 345 - 354
Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment Zoë PhilipsLaura BojkeSu Golder Review Article 09 October 2012 Pages: 355 - 371
Post-Exposure Influenza Prophylaxis with Oseltamivir Beate SanderFrederick G. HaydenLouis P. Garrison Jr Original Research Article 09 October 2012 Pages: 373 - 386
A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy Aslam H. AnisHuiying SunMarc Brisson Original Research Article 09 October 2012 Pages: 387 - 400
Productivity Costs in Health-State Valuations Marieke KrolWerner BrouwerPedram Sendi Original Research Article 09 October 2012 Pages: 401 - 414
Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women Stephanie Land Correspondence 09 October 2012 Pages: 415 - 416
The Authors’ Reply Richard J. MilneKathy H. Heaton-BrownAlison Cubitt Correspondence 09 October 2012 Pages: 416 - 417